Please assess the completion status of the following clinical trial:

Trial Title: The Role of Obstructive Sleep Apnea in Children With Fatty Liver Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Sleep Apnea as diagnosed by clinical sleep study (Apnea Hypopnea index greater than 1)~* Evidence of NAFLD as diagnosed by screening MRI (hepatic fat fraction ≥5.5%) Obese child/adolescent between 9-21 years old~* Compliance with using C-pap as instructed~Exclusion Criteria:~* Medications or know disease known to alter glucose or insulin metabolism such as oral steroids, or certain psychiatric medications, such as Xeleca, Lithium and Paxil.~* Type 2 Diabetes Mellitus~* Medications for chronic anti-inflammatory effects~* Consumption of alcohol

- Gender: ALL
- Minimum Age: 9 Years
- Maximum Age: 21 Years
- Healthy Volunteers: f

Study Arms:
- C-PAP intervention (Type: EXPERIMENTAL): Continuous positive airway pressure is a commonly prescribed therapy for obstructive sleep apnea which is recommended for the treatment of obstructive sleep apnea in children and adults.

Based on this trial design, predict the completion outcome and termination type (if applicable).